What Is Bronchogen Peptide? Key Insights, Benefits & Dosage

The bronchogen peptide is a short synthetic peptide bioregulator from the Khavinson research tradition, formulated to support and regenerate the tissues of the lungs and bronchial mucosa. This guide covers what Bronchogen is, how the bronchogen peptide bioregulator for the lungs is thought to work, its reported benefits, dosage, side effects, and how to find Bronchogen for sale safely.

Michael Phelps

Founder & Peptide Research Specialist, PrymaLab

Published November 8, 2025 · Updated July 5, 2026 · ~12 min read

What Is Bronchogen Peptide?

So, the bronchogen peptide — what is it, exactly? Bronchogen (sometimes misspelled "broncogen") is a specialized peptide bioregulator and bioregulatory peptide formulated to target, support, and regenerate the tissues of the lungs and the bronchial mucosal lining. It belongs to a class of compounds known as synthesized short peptides for the lungs, and it is tissue-specific: it is intended to act on the respiratory tract rather than the whole body.

In scientific terms, the tetrapeptide Bronchogen is an artificially synthesized short-chain geroprotective peptide consisting of four amino acids — Alanine, Aspartic acid, Glutamic acid, and Leucine (Ala-Glu-Asp-Leu, or AEDL). Because it has a low molecular weight, it is proposed to pass through the digestive system via oral administration, enter the bloodstream, and reach the cells of the respiratory tissues. As a bronchogen khavinson peptide, it shares the research lineage of other Khavinson bioregulators such as Chonluten, Vesugen, and Cardiogen.

Form and Labeling

Bronchogen is most often supplied as bronchogen peptide capsules, frequently labeled as a "Bronchogen 20mg" peptide complex. In most countries, including the United States, it is classified as a dietary supplement rather than a pharmaceutical, so no prescription is typically required — though you should always confirm the current legal status in your own region.

Because search phrasings vary, you may also find this compound under queries such as "bronchogen peptide what is it," "what is bronchogen peptide used for," "bronchogen peptide khavinson," "bronchogen peptide bioregulator lungs," "bronchogen peptide bioregulator bronchial," and "bronchogen peptide lung bioregulator." Each refers to the same Ala-Glu-Asp-Leu respiratory bioregulator described here, aimed at optimizing respiratory health and overall lung health.

How Does the Bronchogen Peptide Work?

If you are wondering how lung bioregulators work, the answer lies in tissue specificity and epigenetic regulation. The amino-acid sequence of the bronchogen peptide bioregulator is proposed to be keyed to the respiratory system, so that it interacts mainly with the cells of the lungs, bronchial tubes, and respiratory mucosa. In the Khavinson model, the bronchogen peptide bioregulator for the lungs is proposed to work on bronchial epithelial cells in stages:

1. Cellular penetration: the small four-amino-acid molecule crosses into respiratory cells and reaches the nucleus.
2. DNA binding: it seeks out a specific promoter region on the DNA.
3. Gene activation: binding is proposed to make that gene accessible for transcription, potentially influencing markers like NKX2-1, interacting with specific transcription factors like FOXA1 to modulate gene expression.
4. Protein synthesis: the cell transcribes and translates the structural proteins the lung tissue needs, such as surfactant protein B, to maintain healthy surfactant production and regulate alveolar surface tension.
5. Cellular restoration: with fresh proteins, the cell can repair damage, facilitating cellular regeneration and broader tissue regeneration to function more like a younger cell.

Bronchial Mucosa Repair and Local Immunity

A key proposed action of the bronchogen peptide bioregulator for the bronchial lining is supporting the bronchial epithelium, specifically the ciliated cells and club cells that sweep debris out of the lungs and addressing goblet cell hyperplasia or squamous metaplasia to manage protective MUC5AC mucus production. By supporting this lining and modulating the local inflammatory response and immune response, including the production of secretory immunoglobulin A, Bronchogen is proposed to help restore the lungs' self-cleaning mechanism and improve mucociliary clearance. It is also discussed in the context of local immunity — supporting secretory IgA, CXCL12, NKX2-1, SCGB3A2, and SCGB1A1 expression in the BALF, and healthy alveolar macrophage signaling. These are mechanistic, largely preclinical observations involving the analysis of bronchoalveolar lavage fluid, not proven human outcomes.

Bronchogen Peptide Benefits

Because it is proposed to operate at the level of cellular repair, the reported bronchogen benefits cascade into broader pulmonary function, respiratory capacity, and respiratory health. The primary bronchogen peptide benefits discussed in bioregulator literature include:

• Supporting age-related lung decline: proposed to support elastin, collagen, and surfactant production in the lung matrix, helping maintain elasticity.
• Improving lung capacity after illness: studied for accelerating repair of microscopic lesions and reversing squamous metaplasia after respiratory infections.
• Bronchial support in smokers and ex-smokers: proposed to support regeneration of the bronchial lining damaged by smoke and reverse signs of squamous metaplasia.
• Reducing airway hyper-reactivity: discussed as foundational support that may lessen bronchogen peptide asthma-related flare frequency over time (not an acute rescue treatment).
• Environmental protection: proposed to help lungs clear daily pollutants more efficiently and mitigate oxidative damage.

The honest limitation: there are no large independent randomized human trials establishing efficacy for the bronchogen peptide. It cannot regrow destroyed alveoli and will not "cure" chronic obstructive lung pathology like COPD; frame it as quality-of-life support, and treat overnight-cure claims as marketing.

Bronchogen vs. Taxorest: Synthesized vs. Natural

Bronchogen (a synthesized "cytogen") is often compared with Taxorest, a natural lung extract ("cytomax"). Synthesized peptides are exact copies of the active molecule and act faster; natural extracts act more slowly but may nourish tissue longer. Many protocols start with Bronchogen to kickstart repair, then follow with Taxorest to maintain results.

Bronchogen Peptide Dosage and Administration

Because Bronchogen is not an approved medicine, there is no official human dose. The bronchogen dosage figures below reflect supplier and bioregulator literature and should be treated as research parameters only. The reported bronchogen peptide dosage protocol is:

1. Confirm the format — oral capsules containing lyophilized powder (often a Bronchogen 20mg peptide complex), stable through digestion, unlike injectable versions requiring reconstitution with bacteriostatic water.
2. Standard dose — 1-2 capsules daily, taken 15-30 minutes before meals, for 10-30 days.
3. Maintenance — run 20-30 day cycles two to three times per year.
4. Intensive recovery — 2 capsules twice daily for 30 days, then a 1-2 month break.
5. Support the protocol — stay consistent, hydrate well, store properly, and document results.

Synergistic Bronchogen Stacks

In the Khavinson framework, organs do not work in isolation, so Bronchogen is often "stacked" with other tissue bioregulators or systemic repair peptides like BPC-157 and GHK-Cu:

• Respiratory-immune (Bronchogen + Vladonix): pairs lung repair with thymus/immune support to guard against secondary infection.
• Cardiopulmonary (Bronchogen + Ventfort): adds vascular support for the pulmonary capillaries to enhance respiratory capacity — of interest to athletes targeting VO2 max.
• Mucosal repair (Bronchogen + Stamakort): addresses silent acid reflux that can irritate the bronchial tubes by also supporting the gastric lining.

Always consult a peptide-literate healthcare professional before advanced stacking.

Safety and Side Effects

Reports from its originating research tradition describe a favorable safety profile: as a short peptide of natural amino acids, Bronchogen is said to be well tolerated, with no documented dependency or overdose risk because excess is metabolized. Reported bronchogen peptide side effects are uncommon and mild — occasionally short-lived gastrointestinal upset when first starting. Independent, large-scale human trial data remain limited, so read these reports as encouraging rather than definitive.

Precautions: avoid during pregnancy or breastfeeding unless a physician advises otherwise; use pediatric dosing only under medical supervision; and check the capsule's inactive ingredients (gelatin or cellulose shell, fillers) for personal allergies.

Where to Find Bronchogen for Sale Safely

As peptide therapy grows, so does the number of vendors. Finding legitimate bronchogen for sale requires diligence — read bronchogen peptide reviews, but buy on documentation rather than hype. Use the checklist below.

You can use PrymaLab's bioregulator catalog as a reference point for the transparency standards a trustworthy supplier should meet.

Frequently Asked Questions

What is Bronchogen peptide and what is it used for?

Bronchogen is a synthesized short-chain peptide bioregulator (the tetrapeptide Ala-Glu-Asp-Leu) designed to support and regenerate lung and bronchial tissue. It is used mainly to support recovery after respiratory illness, age-related lung decline, and bronchial health in smokers. In the Khavinson model it acts epigenetically, potentially influencing factors like FOXA2, to drive repair-related protein synthesis.

What are the main Bronchogen peptide benefits?

Reported bronchogen peptide benefits include supporting lung elasticity with age, improving lung capacity after illness, aiding bronchial repair in smokers, easing airway hyper-reactivity over time, and helping the lungs clear pollutants. Evidence is largely preclinical and from its originating research school, so strong disease claims should be treated cautiously.

What is the recommended Bronchogen peptide dosage?

A common bronchogen dosage is 1-2 capsules daily, taken 15-30 minutes before meals, for 10-30 days, with cycles run two to three times per year. For intensive recovery, some protocols use 2 capsules twice daily for 30 days, followed by a one-to-two-month break. These are research parameters, not medical directions.

Can the Bronchogen peptide help with asthma?

Bronchogen is not an acute rescue medication for asthma attacks. Some people use it as foundational support for conditions like chronic obstructive pulmonary disease, on the premise that reducing pro-inflammatory cytokines, neutrophilic inflammation, and chronic inflammatory activity may lower airway hyper-reactivity over time. This use is not clinically proven, so anyone with asthma should discuss it with their pulmonologist first.

Are there Bronchogen peptide side effects?

Reported bronchogen peptide side effects are uncommon and mild, most often brief gastrointestinal upset when first starting. Its originating research tradition reports no dependency or overdose risk because excess peptide is metabolized. Independent human trial data are limited, so pregnant or nursing people and children should consult a professional first.

Where can I find Bronchogen for sale, and do I need a prescription?

In most countries, including the US, Bronchogen is sold as a dietary supplement, so no prescription is typically required — but confirm your local rules. Look for bronchogen for sale from suppliers who state the Ala-Glu-Asp-Leu composition, provide third-party COAs, and avoid cure-all claims or suspiciously low prices.

Is Bronchogen a Khavinson peptide?

Yes. The bronchogen khavinson peptide comes from the bioregulator research tradition associated with Professor Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology, which developed short, tissue-specific peptides — including synthesized respiratory peptides — to support organ-specific repair.

References & Further Reading